Your SlideShare is downloading. ×
Using nutrigenomics to study ranges and plasticity in homeostasis
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Using nutrigenomics to study ranges and plasticity in homeostasis

1,203

Published on

"Using nutrigenomics to study ranges and plasticity in homeostasis" …

"Using nutrigenomics to study ranges and plasticity in homeostasis"
Lecture on 6 Oct. 2011 at ILSI conference in Prague "Health benefits of foods"

Published in: Health & Medicine, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,203
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
47
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • Inflammation has been associated with many disease phenotypes including steatohepatitis or diabetes. This relationship is in particular when inflammation is chronic or non-resolving. There is an interaction between metabolism and inflammation with positive or negative consequences with respect to organ and systemic health.In my talk I will briefly discuss two unpublished studies, one investigating the important interaction of WAT and liver in particular under conditions of diet-induced obesity. Organ-specific macrophages in WAT and liver play an crucial role in progressing organ-specific inflammatory phenotypes. In the second study we found very interesting interaction between dietary fat and macrophages in mesenteric lymph nodes that are exposed postprandially to very high concentrations of chylomicrons. We used a k.o. mouse for ANGPTL4 and could show that chronic consumption of saturated fat can be deadly.
  • Haematoxylin and eosin staining (D) and oil red O staining (E) of representative liver sections of the 4 subgroups
  • (Immuno)histochemical staining confirms enhanced inflammation and early fibrosis in HFH miceImmunohistochemical staining of macrophage activation in representative liver section of HFL and HFH mice using antibody against the specific macrophagemarker Cd68Collagen staining using fast green FCF/sirius red F3B. Staining of stellate cell activation using antibody against GFAP.
  • - Number of genes up- or down-regulated in the various subgroups in comparison to the LFL mice, as determined by Affymetrix GeneChip analysis. Genes with a p-value below 0.05 were considered significantly regulated. - Heat map showing changes in expression of selected genes involved in lipid metabolism, inflammation and fibrosis in liver. Changes in gene expression of selected genes as determined by real-time quantitative PCR. Mean expression in LFL mice was set at 100%. Error bars reflect standard deviation. Bars with different letters are statistically different (P<0.05 according to Student’s t-test). Number of mice per group: n=4 (LFL, HFL, HFH), n=6 (LFH).
  • Haematoxylin and eosin staining of representative adipose tissue sections. Immunohistochemical staining of macrophages using antibody against Cd68. Collagen staining using fast green FCF/sirius red F3B.
  • Adipose tissue mRNA expression of a selected group of genes was determined by quantitative real-time PCR after 21 weeks of dietary intervention. Mean expression in LFL mice was set at 100%. Error bars reflect standard deviation. * = significantly different from HFL mice according to Student’s t-test (P<0.05). Number of mice per group: n=4 (LFL, HFL, HFH), n=6 (LFH).
  • . A) Plasma concentration of haptoglobin, TIMP-1, IL-1β, leptin and insulin were determined by multiplex assay at specific time points during the 21 weeks of dietary intervention after a 6h fast. White squares: LFL, Light grey squares: LFH, dark grey squares: HFL, black squares: HFH. Error bars reflect standard deviation. * = significantly different from HFL mice according to Student’s t-test (P<0.05). Number of mice per group: n=4 (LFL, HFL, HFH), n=6 (LFH).
  • Graphs illustrating the result of multivariate analysis showing the association of protein plasma concentrations at various time points with final liver triglyceride content. Significant proteins display an inverse RSD value higher than 2 (bold line indicates the inverse RSD threshold value of 2).RSD = Relative standard deviation.
  • Transcript

    • 1. Using nutrigenomics to study ranges and plasticity in homeostasis
      http://twitter.com/nutrigenomics
      Michael MüllerNetherlands Nutrigenomics Centre
      & Nutrition, Metabolism and Genomics GroupDivision of Human Nutrition, Wageningen University
    • 2. Our scientific challenge: What's healthy?
    • 3. Metabobolic homeostasis & syndrome
    • 4. Metabolic health = plasticity / flexibility
      The personal genome is the starting point & we can get comprehensive information about it but we should not underestimate the challenges of“bioinformatics & databasing”
      Health is dynamic: The property to adapt to metabolic perturbations / challenges
      Feeding / fasting => autophagy => cellular homeostasis & “exercise”
      Caloric restriction => chromatin “exercise”
      Food bioactives that modulate transcription (e.g. via nuclear receptors) or chromatin activity (nutriepigenome) => cell & organ “exercise”
      4
    • 5. Phenotype plasticity
      Phenotypic plasticity is the ability of an organism to change its phenotype in response to changes in the environment => nutrition, lifestyle
    • 6. Duality of biological information:Epigenetic & Genetic
    • 7. Modern Nutritional Science with Nutrigenomics Quantification of the nutritional phenotype
      Lifestyle
      NutritionFoods
      Microbiota
      Environment
    • 8. Timelyrelatively modest interventions in early life can have a large effect on disease risk later
    • 9. Nutrigenomics – molecular nutrition and genomics
      5 -10,000 (?)metabolites
      90,000 (?)proteins
      100,000 (?) transcripts
      20,210 genes
      Müller & Kersten
      Nature Reviews Genetics 2003
    • 10. Understanding NutritionHow nutrients regulate our genes: via sensing molecular switches
      Changed organ metabolic capacity
      Am J ClinNutr. 2009; 90:415-24Am J ClinNutr. 2009;90:1656-64Mol CellBiology2009;29:6257-67
      Am J ClinNutr. 2010;91:208-17BMC Genomics2009
      Physiol. Genomics2009Circulation 2010Diabetes 2010
      Cell Metabolism 2010Nature 2011
      Am J Clin Nutr. 2007;86(5):1515-23
      PLOS ONE 2008;3(2):e1681 BMC Genomics 2008; 9:231BMC Genomics 2008; 9:262J Biol Chem. 2008;283:22620-7Arterioscler Thromb Vasc Biol. 2009;29:969-74.
      Plos One 2009;4(8):e6796HEPATOLOGY 2010;51:511-522
      J Clin Invest. 2004;114:94-103
      J Biol Chem. 2006;28:934-44
      Endocrinology. 2006;147:1508-16
      Physiol Genomics. 2007;30:192-204Endocrinology. 2007;148:2753-63
      BMC Genomics 2007; 8:267 Arterioscler Thromb Vasc Biol. 2007;27:2420-7
    • 11. Dose-dependent effects of dietary fat on development of obesity in relation to intestinal differential gene expression in C57BL/6J mice
      PLOS one 2011
    • 12. Robust & concentration dependent effects in small intestineDifferentially regulated intestinal genes by high fat diet
      C1
      C2
      C3
      C4
      C5
      C6
      C7
      C8
      C9
      C10
      PLOS one 2011
    • 13. Cellular localization and specific lipid metabolism-related function of fat-dose dependently regulated genes
      PLOS one 2011
    • 14. Intestinal capacity for lipid absorption
      40 cm
      4 cm
      C1
      C2
      C3
      C4
      C5
      C6
      C7
      C8
      C9
      C10
      Microbiota
      10% FAT
      45% FAT
    • 15.
    • 16. Dangerous interaction - The two hitsStress from Metabolism & Inflammation
    • 17. Liver, FAT & NASH/NAFLD
      • Nonalcoholic Fatty Liver Diseases (NAFLD):Liver component of Metabolic Syndrome
      • 18. Different stages in NAFLD progression:
      • 19. Molecular events involved in NASH pathogenesis:
      • 20. Role of PPARa (Endocrinology 2008 & Hepatology 2010)
      • 21. Role Kupffer cells (Hepatology 2010)
      • 22. Role of macrophages in lipid metabolism (JBC 2008; Cell Metabolism 2010)
      hepatic steatosis steatohepatitis (NASH) & fibrosiscirrhosis
    • 23. Experimental Design
      tissue collection
      run-in diet
      20 weeks diet intervention
      • plasma collection
      multiple proteinassays
      • liver
      • 24. stratification on body weight
      frozen sections: histological feat.
      lipid content
      RNA extraction:Affx microarrays
      10 LFD
      0
      2
      4
      8
      12
      16
      20 weeks
      20 LFD
      -3
      quality control & data analysis pipeline
      10 HFD
      Mouse genome
      430 2.0
      10% low
      fat diet
      (palm oil)
      45% high fat diet (palm oil)
      • ep. white adipose tissue
      paraffin sections: histological feat.
      RNA extraction: real-time PCR
    • 25. High fat diet-induced obesity
      0
      2
      4
      8
      12
      16
      20
      HFL
      LFL
      HFH
      LFH
      25
      20
      *
      *
      15
      **
      BW gain (g)
      *
      10
      *
      *
      *
      *
      5
      0
      weeks under diet intervention
      Liver TG content
      Hepatomegaly
      ALT plasma activity
      200
      10
      100
      ***
      ***
      **
      160
      8
      80
      **
      120
      6
      60
      *
      Ratio LW/BW (%)
      mg TG/g liver
      ALT activity (UI)
      80
      4
      40
      *
      *
      40
      2
      20
      0
      0
      0
      LFL
      LFH
      HFL
      HFH
    • 26. The HFH mice develops NASH
    • 27. Immunohistochemicalstaining confirms enhanced liver inflammation and early fibrosis in HFH mice
      Macrophage CD68
      Collagen
      Stellate cell GFAP
    • 28. Upregulation of inflammatory and fibrotic gene expression in HFH responder mice
    • 29. Adipose dysfunction in HFH mice
    • 30. Change in adipose gene expression indicate adipose tissue dysfunction
    • 31. Plasma proteins as early predictive biomarker for NASH in C57Bl/6 mice
    • 32. Plasma proteins as early predictive biomarker for NASH in C57Bl/6 mice
      Multivariate analysis of association of protein plasma concentrations with final liver triglyceride content
    • 33. Conclusions
      Our data support the existence of a tight relationship between adipose tissue dysfunction and NASH pathogenesis.
      It points to several novel potential predictive biomarkers for NASH.
      Duval C, Thissen U, Keshtkar S, Accart B, Stienstra R, Boekschoten MV, Roskams T, Kersten S, Müller M. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. Diabetes. 2010;59:3181-91.
    • 34. Plasma Protein Profiling Reveals Protein Clusters Related to BMI and Insulin Levels in Middle-Aged Overweight Subjects
      AIM
      Associate plasma protein profiles with BMI
      Identifypotential marker profile of earlydisease state
      . PLoS One. 2010 Dec 23;5(12):e14422
    • 35. Measurements
      RulesBasedMedicine (Austin, USA)
      Multiplex immunoassay
      In total 124 proteinsmeasured
      Involved in diseases, inflammation, endothelialfunction and metabolism
      . PLoS One. 2010 Dec 23;5(12):e14422
    • 36. We are different: improved phenotyping necessary to reveal phenotype clusters
      . PLoS One. 2010 Dec 23;5(12):e14422
    • 37. Fish-oil supplementation induces anti-inflammatory gene expression profiles in human blood mononuclear cells
      Less inflammation & decreased pro-arteriosclerosis markers= Anti-immuno-senescence
      Bouwens et al. Am J ClinNutr. 2009
    • 38. Very personal conclusionsHow to keep our metabolic plasticity/health
      Identify chronic (non-resolving) stress using systems “perturbation” tests & deep genomics-based phenotyping
      Solve it!
      Less Inflammation
      Less Metabolic Stress (sat. fat, lipogenic foods)
      More Exercise (muscle & other organs) with a “challenging” lifestyle & food pattern
      Eat less from time to time
      32
    • 39. 2 Meals a day, work as long as possible & embrace challenge
      Walter Breuning (1896 - 2011)
    • 40. Sander KerstenLinda SandersonNatasha Georgiadi
      Mark BouwensLydia Afman
      Guido Hooiveld
      Meike Bunger
      Philip de Groot
      Mark Boekschoten
      Nicole de Wit
      Mohammad Ohid Ullah
      Christian Trautwein
      Folkert Kuipers
      Ben van Ommen
      Hannelore Daniel
      Bart Staels
      Edith Feskens
      …..

    ×